Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at Dec. 31, 2023	$ 555,192	$ 83	$ 750,737	$ 207	$ (195,835)
Balance, shares at Dec. 31, 2023		83,435,513
Issuance upon vesting of restricted stock units		$ 1	(1)
Issuance upon vesting of restricted stock units, shares		729,032
Issuance of common stock under employee stock purchase plan	150		150
Issuance of common stock under employee stock purchase plan, shares		58,555
Stock-based compensation expense	12,586		12,586
Other comprehensive income (loss)	(388)			(388)
Net loss	(63,169)				(63,169)
Balance at Mar. 31, 2024	504,371	$ 84	763,472	(181)	(259,004)
Balance, shares at Mar. 31, 2024		84,223,100
Balance at Dec. 31, 2024	438,867	$ 84	802,770	233	(364,220)
Balance, shares at Dec. 31, 2024		84,463,059
Issuance of common stock upon vesting of restricted stock units, net of employee tax obligations	(485)	$ 1	(486)
Issuance of common stock upon vesting of restricted stock units, net of employee tax obligations, shares		1,062,120
Issuance of common stock under employee stock purchase plan	138		138
Issuance of common stock under employee stock purchase plan, shares		54,296
Stock-based compensation expense	6,951		6,951
Other comprehensive income (loss)	(115)			(115)
Net loss	(34,272)				(34,272)
Balance at Mar. 31, 2025	$ 411,084	$ 85	$ 809,373	$ 118	$ (398,492)
Balance, shares at Mar. 31, 2025		85,579,475